Tag: Pharmaceutical industry news
Trump’s Drug Pricing Plan Update and Moderna’s Strategic Shift in Pharmalittle News
Well, hey there, folks! How's it going on this fine day? We're hanging in there, thank you very much, especially since we've hit the midpoint of the week. I mean, we've made it this...
NIH Patent Freeze, Senate Hearing for FDA Chief: Pharmalittle Update
The National Institutes of Health (NIH) technology transfer offices have hit a roadblock, halting the filing of new patent applications and restricting the licensing of existing ones for the past five weeks, as reported...
Challenges at FDA & bluebird Bio Sale: What You Need to Know
This morning, Praxis Precision Medicine announced that an independent data monitoring committee recommended discontinuing a Phase 3 study involving its experimental treatment for essential tremors. The analysis indicated that the drug was unlikely to...
U.K. Restricts Lilly’s Obesity Drug, Pharma Layoffs, and More: Pharmalittle Update
U.K. Restricts Lilly's Obesity Drug to Those in Greatest NeedIn a move to adapt to the rising demand for obesity treatment, the U.K. announced that it will be offering Eli Lilly's weight loss drug,...
Merck Drug Trial and Wegovy in China: Pharmalittle News Update
Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...
Pharmalittle: RFK Jr. Vaccines Scandal & Kids’ Obesity Drug Prescriptions
Good morning and welcome to a new week of work. We hope you had a refreshing weekend because now it's time to get back to the usual routine of online meetings, phone calls, and...
Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update
As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see a college campus, or catching up on reading, there are...
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
Pharmalittle: Updates on Charles River Monkey Shipments and VC Partners in China
Good day to you! The sun is shining, the birds are singing, and the Pharmalot campus is buzzing with activity. We're starting our day with a delicious cup of hot buttery rum coffee, sweetened...
FDA Oversight of Drug Shortages and AstraZeneca Threats: Pharmalittle News Update
As the week comes to a close, many are looking forward to weekend plans. Whether it's enjoying the outdoors, planning a holiday break, or connecting with loved ones, there are plenty of ways to...
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...
Italian Acquisition and Medicare Advantage Market Growth in the Latest Pharmalittle Update
Good morning! This is Adam Feuerstein reporting from the Pharmalittle campus in Cambridge, Mass., filling in for our regular host Ed. Like Mr. Pharmalot, I start my day with a cup of coffee and...